drugset / Trial / NCT06091267
PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes
RandomizedCrossoverOpen-labelTreatment
Summary
This is an Open-Label, Crossover, Pharmacokinetic and Efficacy Bridging Study of Oral ASTX727 versus IV Decitabine in Chinese Subjects with Myelodysplastic Syndromes
Timeline
- Start
- 2023-10-16
- Primary completion
- 2026-05-31
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASTX727 | Unknown | — | — |
| Subject | Decitabine | Small molecule | 20 mg/m2 | Intravenous |